Tissue cross-reactivity studies of CPGJ701 in humans, cynomolgus monkeys and Sprague-Dawley rats and correlation analysis with in vivo toxicity

BACKGROUND: CPGJ701 is a recombinant humanized anti-human epidermal growth factor receptor-2 (HER2) monoclonal antibody-derivative of the cytotoxic agent maytansine (DM1) conjugate for the treatment of HER2-positive metastatic breast cancer. Tissue cross-reactivity (TCR) studies of CPGJ701 in a comp...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Transl Med
Prif Awduron: Qu, Zhe, Lyu, Jianjun, Liu, Yue, Wang, Xin, Lin, Zhi, Yang, Yanwei, Zhang, Di, Geng, Xingchao, Li, Bo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7186683/
https://ncbi.nlm.nih.gov/pubmed/32355769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.106
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg